Pyxis Oncology (PYXS) Amortization - Intangibles (2023 - 2025)

Pyxis Oncology (PYXS) has 3 years of Amortization - Intangibles data on file, last reported at $375000.0 in Q4 2025.

• Amortization - Intangibles for Q4 2025 came in at $375000.0, down 75.54% year-over-year; the trailing twelve-month figure through Dec 2025 was $3.0 million (down 51.55% YoY), and the FY2025 annual result was $3.0 million, down 51.55% from the prior year.
• Amortization - Intangibles declined to $375000.0 in Q4 2025 per PYXS's latest filing, from $532000.0 in the prior quarter.
• Over five years, Amortization - Intangibles peaked at $1.7 million in Q3 2024 and troughed at $375000.0 in Q4 2025.
• A 3-year average of $1.2 million and a median of $1.3 million in 2023 frame the typical range for Amortization - Intangibles.
• The sharpest annual moves came in 2024 and 2025: Amortization - Intangibles soared 112.19% in 2024, then plunged 75.54% in 2025.
• A 3-year view of Amortization - Intangibles shows it stood at $1.4 million in 2023, then advanced by 6.38% to $1.5 million in 2024, then sank by 75.54% to $375000.0 in 2025.
• Business Quant data shows PYXS's Amortization - Intangibles at $375000.0 in Q4 2025, $532000.0 in Q3 2025, and $896000.0 in Q2 2025.